Literature DB >> 12207621

Scleroderma-like drug reaction to paclitaxel (Taxol).

S Läuchli, R M Trüeb, M Fehr, J Hafner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12207621     DOI： 10.1046/j.1365-2133.2002.488210.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

Review 1.  Environmental risk factors of systemic sclerosis.

Authors:  Isabelle Marie; Jean-François Gehanno
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

Review 2.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

3.  Docetaxel-induced Scleroderma in A Breast Cancer Patient: A Case Report.

Authors:  Murat Özgür Kılıç; Metin Yalaza; Celal İsmail Bilgiç; Cenap Dener
Journal:  J Breast Health       Date:  2015-04-01

4.  Radiotherapy of early breast cancer in scleroderma patients: our experience with four cases and a short review of the literature.

Authors:  George Kyrgias; Kiki Theodorou; Anna Zygogianni; Konstantinos Tsanadis; Stefanos Zervoudis; John Tzitzikas; Michael Koukourakis
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-01-24

Review 5.  Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.

Authors:  Thanika Ketpueak; Wanitcha Chanloung; Kittiya Na Nan; Chontara Pongsananurak; Nuntana Kasitanon; Worawit Louthrenoo
Journal:  Clin Rheumatol       Date:  2022-09-09       Impact factor: 3.650
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.